@DeepSailCapital Isn't $400 what the provider receives, not what $SNWV receives? The provider then pays $SNWV for the applicator and keeps the rest. The issue is the providers are being paid too much in light of what they pay $SNWV for applicators and their actual time to treat.
@DeepSailCapital Lower provider payments would hit demand, but is the "nominator" directly attacking SNWV's profitability, or is the nominator saying that wound care providers are being paid too much in light of what they pay SNWV (alleged 4x provider markup on kits) and actual treatment times?
@CorpusCol@PhillyFanLife Mets' lineup has been putrid all year with injuries and many sub-.300 OBPs (Bichette, Semien, Vientos, Torrens) . . . and they've scored 11 more runs than the Phillies. Incredible how bad Turner, Bohm, Stott, Garcia, and Realmuto colletively have been (Crawford gets a pass)
$EXSR announces dividend increase and, much more surprisingly for them, a buyback, which makes sense given the overcapitalization:
https://t.co/CHNSZAr1RE
$EXSR NIM expansion continues here as very low-yielding securities mature, higher interest borrowing gets paid off, and some loan growth. Still more to go on both borrowing payoff and low-yield securities maturing, so NIM expansion should continue. But need to watch credit.
$EXSR NIM expansion continues here as very low-yielding securities mature, higher interest borrowing gets paid off, and some loan growth. Still more to go on both borrowing payoff and low-yield securities maturing, so NIM expansion should continue. But need to watch credit.
@Ron284Ron $EXSR Even without significant declines in long term rates, there should be alot of book value growth in the next few years from unwinding the AOCI losses in the securities portfolio. Assuming no big credit issues, the current share price could be 0.6x - 0.5x book in 2 years.
$TRUX Based on the call report, continued great results. Bank-level net income up 36% y-o-y (helped by a small negative loan loss provision), with NII up 39% (loan growth + NIM expansion) and fiduciary (trust) income up 14%. Screening for TBV discounts will miss this gem.
@CambriaCreek I'm a long-timer holder, so hope you're correct. But what gives you confidence on ~35% incremental EBITDA margin on the next ~$13 million in revenue given EBITDA margin of ~9% in both 2019 and 2025, i.e., no SG&A leverage yet despite 2x sales (though less growth in real terms)
@MackinacCap Are you concerned by metric creep here. From sessions to core sessions to off-platform views. Continually slicing differently to show growth on some metric when the whole pie isn’t really growing.
@atelicinvest@thespencerwalsh IAC has managed to hang on so far. Biggest impact should be to digital revenue of People segment. But that is up through Q3 2025 (they report Q4 tonight), though "sessions" (i.e., page visits) are down. See page 4:
https://t.co/TfvokhJUCD
$PFSB Earnings release not out yet, but call report looks fine. Steady earnings and no big credit issues. Buybacks should continue at a nice discount to book.
And despite lobbying by CDFIs, the current bill does not include any date by which either last year's or this year's CDFI allocation must be spent. So last year's and this year's allocation may expire unused, and with them $8 - $10 million/year in CDFI grants to UBAB.
2/2
$UBAB Perhaps some credit concerns popping up, and what is going to happen with the CDFI Fund? Congress rejected WH proposal and allocated $324 million in the recent compromise bill. But will the Trump Admin spend it? To date it has not spent last year's allocation.
/1
$THVB Growing loans by 15% and increasing an already high loan loss reserve % suggests a significant drag on y-o-y earnings due to significantly larger loss provision. Yet THVB still managed to grow earnings by 14% (20% PTPP). Impressive. And credit quality remains good.
@ragingbullcap The 2026 slate as a whole looks good for $DBO, e.g., June has Masters of the Universe, Disclosure Day, Toy Story 5, and Supergirl, while July has Minions 3, Moana, The Odyssey, and Spider-Man. Those don't all of the DBOX appeal of Avengers, but I expect a big box office overall.